APA (7th ed.) Citation

L, O., AH, M., Y, M., MR, S., S, J., M, H., & M, A. (2026). CD20-directed antibody-drug conjugates in non-hodgkin lymphoma: Translating preclinical promise into clinical reality. Journal of hematology & oncology, 19(1), . https://doi.org/10.1186/s13045-026-01807-5

Chicago Style (17th ed.) Citation

L, Omidvar, Mer AH, Mirzaei Y, Sanaye-Pasand MR, Jahandideh S, Hassani M, and Abdollahpour-Alitappeh M. "CD20-directed Antibody-drug Conjugates in Non-hodgkin Lymphoma: Translating Preclinical Promise into Clinical Reality." Journal of Hematology & Oncology 19, no. 1 (2026). https://doi.org/10.1186/s13045-026-01807-5.

MLA (9th ed.) Citation

L, Omidvar, et al. "CD20-directed Antibody-drug Conjugates in Non-hodgkin Lymphoma: Translating Preclinical Promise into Clinical Reality." Journal of Hematology & Oncology, vol. 19, no. 1, 2026, https://doi.org/10.1186/s13045-026-01807-5.